Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

69 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Comparison between 1.5-T and 3.0-T MRI for the diagnosis of placenta accreta spectrum disorders.
Bourgioti C, Zafeiropoulou K, Tzavara C, Daskalakis G, Fotopoulos S, Theodora M, Nikolaidou ME, Konidari M, Gourtsoyianni S, Panourgias E, Koutoulidis V, Martzoukos EA, Konstantinidou AE, Moulopoulos LA. Bourgioti C, et al. Among authors: koutoulidis v. Diagn Interv Imaging. 2022 Sep;103(9):408-417. doi: 10.1016/j.diii.2022.04.005. Epub 2022 May 12. Diagn Interv Imaging. 2022. PMID: 35568666 Free article.
Ultrasmall particles for Gd-MRI and (68) Ga-PET dual imaging.
Truillet C, Bouziotis P, Tsoukalas C, Brugière J, Martini M, Sancey L, Brichart T, Denat F, Boschetti F, Darbost U, Bonnamour I, Stellas D, Anagnostopoulos CD, Koutoulidis V, Moulopoulos LA, Perriat P, Lux F, Tillement O. Truillet C, et al. Among authors: koutoulidis v. Contrast Media Mol Imaging. 2015 Jul-Aug;10(4):309-19. doi: 10.1002/cmmi.1633. Epub 2014 Dec 5. Contrast Media Mol Imaging. 2015. PMID: 25483609 Free article.
68Ga-radiolabeled AGuIX nanoparticles as dual-modality imaging agents for PET/MRI-guided radiation therapy.
Bouziotis P, Stellas D, Thomas E, Truillet C, Tsoukalas C, Lux F, Tsotakos T, Xanthopoulos S, Paravatou-Petsotas M, Gaitanis A, Moulopoulos LA, Koutoulidis V, Anagnostopoulos CD, Tillement O. Bouziotis P, et al. Among authors: koutoulidis v. Nanomedicine (Lond). 2017 Jul;12(13):1561-1574. doi: 10.2217/nnm-2017-0032. Epub 2017 Jun 16. Nanomedicine (Lond). 2017. PMID: 28621567 Free article.
Dynamic contrast-enhanced magnetic resonance imaging parameters correlate with advanced revised-ISS and angiopoietin-1/angiopoietin-2 ratio in patients with multiple myeloma.
Terpos E, Matsaridis D, Koutoulidis V, Zagouri F, Christoulas D, Fontara S, Panourgias E, Gavriatopoulou M, Kastritis E, Dimopoulos MA, Moulopoulos LA. Terpos E, et al. Among authors: koutoulidis v. Ann Hematol. 2017 Oct;96(10):1707-1714. doi: 10.1007/s00277-017-3078-7. Epub 2017 Aug 1. Ann Hematol. 2017. PMID: 28766001
Recommendations for acquisition, interpretation and reporting of whole body low dose CT in patients with multiple myeloma and other plasma cell disorders: a report of the IMWG Bone Working Group.
Moulopoulos LA, Koutoulidis V, Hillengass J, Zamagni E, Aquerreta JD, Roche CL, Lentzsch S, Moreau P, Cavo M, Miguel JS, Dimopoulos MA, Rajkumar SV, Durie BGM, Terpos E, Delorme S. Moulopoulos LA, et al. Among authors: koutoulidis v. Blood Cancer J. 2018 Oct 4;8(10):95. doi: 10.1038/s41408-018-0124-1. Blood Cancer J. 2018. PMID: 30287814 Free PMC article.
69 results